Amalgamated Bank Theseus Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
SELL
$2.12 - $4.18 $390 - $769
-184 Reduced 10.24%
1,612 $7,000
Q1 2023

May 02, 2023
SELL
$5.21 - $14.05 $547 - $1,475
-105 Reduced 5.52%
1,796 $16,000
Q2 2022

Aug 15, 2022
BUY
$5.04 - $14.05 $1,164 - $3,245
231 Added 13.83%
1,901 $11,000
Q1 2022

Jun 30, 2022
BUY
$8.75 - $14.51 $14,612 - $24,231
1,670 New
1,670 $19,000

Others Institutions Holding THRX

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Theseus Pharmaceuticals, Inc.

THRX Quotes by TradingView
  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email